Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0T1GV
|
|||
Former ID |
DIB001232
|
|||
Drug Name |
ADD-17014
|
|||
Synonyms |
1-(4-Chlorophenyl)-5-(4-pyridyl)-DELTA2-1,2,3-triazoline; 4-[1-(4-Chlorophenyl)-4,5-dihydro-1H-1,2,3-triazol-5-yl]pyridine
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Epileptic seizures [ICD-11: 8A61-8A6Z; ICD-9: 345.9, 780.3] | Discontinued in Phase 1 | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C13H11ClN4
|
|||
Canonical SMILES |
C1C(N(N=N1)C2=CC=C(C=C2)Cl)C3=CC=NC=C3
|
|||
InChI |
1S/C13H11ClN4/c14-11-1-3-12(4-2-11)18-13(9-16-17-18)10-5-7-15-8-6-10/h1-8,13H,9H2
|
|||
InChIKey |
VVRREURVTJNTQQ-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 55643-87-3
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800006181) |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.